Pujol JL - Search Results

1

Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study design.

Garrido P, Pujol JL, Kim ES, Lee JM, Tsuboi M, Gómez-Rueda A, Benito A, Moreno N, Gorospe L, Dong T, Blin C, Rodrik-Outmezguine V, Passos VQ, Mok TS. Garrido P, et al. Among authors: pujol jl. Future Oncol. 2021 Apr;17(12):1459-1472. doi: 10.2217/fon-2020-1098. Epub 2021 Mar 2. Future Oncol. 2021. PMID: 33648347

2

Pilot study of neoadjuvant ifosfamide, cisplatin, and etoposide in locally advanced non-small cell lung cancer.

Pujol JL, Rossi JF, Le Chevalier T, Daurès JP, Rouanet P, Douillard JY, Dubois JB, Arriagada R, Mary H, Godard P, et al. Pujol JL, et al. Eur J Cancer. 1990;26(7):798-801. doi: 10.1016/0277-5379(90)90155-m. Eur J Cancer. 1990. PMID: 2171600

3

Neoadjuvant chemotherapy of locally advanced non-small cell lung cancer.

Pujol JL, Le Chevalier T, Ray P, Gautier V, Rouanet P, Arriagada R, Grunenwald D, Michel FB. Pujol JL, et al. Lung Cancer. 1995 Apr;12 Suppl 1:S107-18. doi: 10.1016/0169-5002(95)00426-2. Lung Cancer. 1995. PMID: 7551918 Review.

4

Long-term results of neoadjuvant ifosfamide, cisplatin, and etoposide combination in locally advanced non-small-cell lung cancer.

Pujol JL, Hayot M, Rouanet P, Le Chevalier T, Michel FB. Pujol JL, et al. Chest. 1994 Nov;106(5):1451-5. doi: 10.1378/chest.106.5.1451. Chest. 1994. PMID: 7956400 Clinical Trial.

5

Clinical evaluation of serum tumour marker CA 242 in non-small cell lung cancer.

Pujol JL, Cooper EH, Lehmann M, Purves DA, Dan-Aouta M, Midander J, Godard P, Michel FB. Pujol JL, et al. Br J Cancer. 1993 Jun;67(6):1423-9. doi: 10.1038/bjc.1993.264. Br J Cancer. 1993. PMID: 8390291 Free PMC article. Clinical Trial.

6

Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study.

Pujol JL, Douillard JY, Rivière A, Quoix E, Lagrange JL, Berthaud P, Bardonnet-Comte M, Polin V, Gautier V, Milleron B, Chomy F, Chomy P, Spaeth D, Le Chevalier T. Pujol JL, et al. J Clin Oncol. 1997 May;15(5):2082-9. doi: 10.1200/JCO.1997.15.5.2082. J Clin Oncol. 1997. PMID: 9164221 Clinical Trial.

7

Immunohistochemical detection of p53 protein and prognosis of surgically resected non-small-cell lung cancer.

Quantin X, Pujol JL, Lehmann M, Simony J, Serre I, Michel FB. Quantin X, et al. Among authors: pujol jl. Cancer Detect Prev. 1997;21(5):418-25. Cancer Detect Prev. 1997. PMID: 9307845

8

Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancer.

Pujol JL, Lafontaine T, Quantin X, Reme-Saumon M, Cupissol D, Khial F, Michel FB. Pujol JL, et al. Chest. 1999 Jan;115(1):144-50. doi: 10.1378/chest.115.1.144. Chest. 1999. PMID: 9925076 Clinical Trial.

9

Concomitant brain radiotherapy and vinorelbine-ifosfamide-cisplatin chemotherapy in brain metastases of non-small cell lung cancer.

Quantin X, Khial F, Reme-Saumon M, Michel FB, Pujol JL. Quantin X, et al. Among authors: pujol jl. Lung Cancer. 1999 Oct;26(1):35-9. doi: 10.1016/s0169-5002(99)00071-9. Lung Cancer. 1999. PMID: 10574679

10

Phase I-II study of high dose epirubicin plus cisplatin in unresectable non-small-cell lung cancer: searching for the maximal tolerated dose.

Quantin X, Rivière A, Daurès JP, Oliver P, Comte-Bardonnet M, Khial F, Marcillac I, Pujol JL. Quantin X, et al. Among authors: pujol jl. Am J Clin Oncol. 2000 Apr;23(2):192-6. doi: 10.1097/00000421-200004000-00017. Am J Clin Oncol. 2000. PMID: 10776983 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters